Regenxbio Inc’s recently made public that its Director Mills Kenneth T. unloaded Company’s shares for reported $0.16 million on May 12 ’25. In the deal valued at $7.91 per share,20,602 shares were sold. As a result of this transaction, Mills Kenneth T. now holds 475,103 shares worth roughly $4.0 million.
Then, KENNETH MILLS bought 20,602 shares, generating $154,927 in total proceeds.
Before that, VITTAL VASISTA bought 20,041 shares. Regenxbio Inc shares valued at $148,504 were divested by the Officer at a price of $7.41 per share.
Goldman downgraded its Regenxbio Inc [RGNX] rating to a Neutral from a a Buy in a research note published on February 11, 2025; the price target was decreased to $14 from $38.
Price Performance Review of RGNX
On Tuesday, Regenxbio Inc [NASDAQ:RGNX] saw its stock fall -4.32% to $8.41. Over the last five days, the stock has lost -1.87%. Regenxbio Inc shares have fallen nearly -41.56% since the year began. Nevertheless, the stocks have risen 8.80% over the past one year. While a 52-week high of $15.36 was reached on 06/02/25, a 52-week low of $5.03 was recorded on 04/09/25.
Levels Of Support And Resistance For RGNX Stock
The 24-hour chart illustrates a support level at 8.15, which if violated will result in even more drops to 7.89. On the upside, there is a resistance level at 8.79. A further resistance level may holdings at 9.17.
How much short interest is there in Regenxbio Inc?
A steep rise in short interest was recorded in Regenxbio Inc stocks on 2025-07-15, growing by 0.67 million shares to a total of 6.18 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 5.51 million shares. There was a rise of 10.8%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 07, 2024 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $38 price target.
